Inventor
BLEICH KIMELMAN NADAV
IL10 patents
⚠️ This page may combine multiple inventors who share the name “BLEICH KIMELMAN NADAV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAPI PHARMA LTD
8 patentsUS11471421B2Oct 18, 2022
Process for preparing microparticles containing glatiramer acetate
MAPI PHARMA LTD2 citations71
US10493122B2Dec 3, 2019
Sublingual delivery of glatiramer acetate
MAPI PHARMA LTD5 citations71
US11167003B2Nov 9, 2021
Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
MAPI PHARMA LTD3 citations66
US12370233B2Jul 29, 2025
Depot systems comprising glatiramer acetate
MAPI PHARMA LTD0 citations59
US11865213B2Jan 9, 2024
Semaglutide depot systems and use thereof
MAPI PHARMA LTD1 citations58
US12343371B2Jul 1, 2025
Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate
MAPI PHARMA LTD0 citations56
US12097292B2Sep 24, 2024
Process for preparing microparticles containing glatiramer acetate
MAPI PHARMA LTD0 citations50
US12514908B2Jan 6, 2026
Semaglutide depot systems and use thereof
MAPI PHARMA LTD0 citations48
STEM CELL MEDICINE LTD
2 patentsUS11413311B2Aug 16, 2022
Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
STEM CELL MEDICINE LTD2 citations67
US12161688B2Dec 10, 2024
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
STEM CELL MEDICINE LTD0 citations57